BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06681922-completion@plaintrial.com
DTSTAMP:20261027T191213Z
DTSTART;VALUE=DATE:202710
SUMMARY:A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide\, 
 Bortezomib\, and Abatacept for the Prevention of Graft-Versus-Host Disease
  (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT
 ) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06681922
URL:https://plaintrial.com/trial/NCT06681922
END:VEVENT
END:VCALENDAR